New Results
AVP-induced counter-regulatory glucagon is diminished in type 1 diabetes
Angela Kim, Jakob G Knudsen, Joseph C Madara, Anna Benrick, Thomas Hill, Lina Abdul Kadir, Joely A Kellard, Lisa Mellander, Caroline Miranda, Haopeng Lin, Tim James, Kinga Suba, Aliya Spigelman, Yanling Wu, Patrick MacDonald, Ingrid Wernstedt Asterholm, Tore Magnussen, Mikkel Christensen, Tina Vilsboll, Victoria Salem, Filip Krag Knop, Patrik Rorsman, Bradford B Lowell, Linford Briant
doi: https://doi.org/10.1101/2020.01.30.927426
Angela Kim
1 Harvard Medical School;
Jakob G Knudsen
2 University of Copenhagen;
Joseph C Madara
1 Harvard Medical School;
Anna Benrick
3 University of Goteborg;
Thomas Hill
4 University of Oxford;
Lina Abdul Kadir
4 University of Oxford;
Joely A Kellard
4 University of Oxford;
Lisa Mellander
3 University of Goteborg;
Caroline Miranda
4 University of Oxford;
Haopeng Lin
5 University of Alberta;
Tim James
6 NHS Oxford;
Kinga Suba
7 Imperial College London
Aliya Spigelman
5 University of Alberta;
Yanling Wu
3 University of Goteborg;
Patrick MacDonald
5 University of Alberta;
Ingrid Wernstedt Asterholm
3 University of Goteborg;
Tore Magnussen
2 University of Copenhagen;
Mikkel Christensen
2 University of Copenhagen;
Tina Vilsboll
2 University of Copenhagen;
Victoria Salem
7 Imperial College London
Filip Krag Knop
2 University of Copenhagen;
Patrik Rorsman
4 University of Oxford;
Bradford B Lowell
1 Harvard Medical School;
Linford Briant
4 University of Oxford;
Article usage
Posted January 31, 2020.
AVP-induced counter-regulatory glucagon is diminished in type 1 diabetes
Angela Kim, Jakob G Knudsen, Joseph C Madara, Anna Benrick, Thomas Hill, Lina Abdul Kadir, Joely A Kellard, Lisa Mellander, Caroline Miranda, Haopeng Lin, Tim James, Kinga Suba, Aliya Spigelman, Yanling Wu, Patrick MacDonald, Ingrid Wernstedt Asterholm, Tore Magnussen, Mikkel Christensen, Tina Vilsboll, Victoria Salem, Filip Krag Knop, Patrik Rorsman, Bradford B Lowell, Linford Briant
bioRxiv 2020.01.30.927426; doi: https://doi.org/10.1101/2020.01.30.927426
AVP-induced counter-regulatory glucagon is diminished in type 1 diabetes
Angela Kim, Jakob G Knudsen, Joseph C Madara, Anna Benrick, Thomas Hill, Lina Abdul Kadir, Joely A Kellard, Lisa Mellander, Caroline Miranda, Haopeng Lin, Tim James, Kinga Suba, Aliya Spigelman, Yanling Wu, Patrick MacDonald, Ingrid Wernstedt Asterholm, Tore Magnussen, Mikkel Christensen, Tina Vilsboll, Victoria Salem, Filip Krag Knop, Patrik Rorsman, Bradford B Lowell, Linford Briant
bioRxiv 2020.01.30.927426; doi: https://doi.org/10.1101/2020.01.30.927426
Subject Area
Subject Areas
- Biochemistry (11745)
- Bioengineering (8752)
- Bioinformatics (29200)
- Biophysics (14972)
- Cancer Biology (12096)
- Cell Biology (17411)
- Clinical Trials (138)
- Developmental Biology (9421)
- Ecology (14182)
- Epidemiology (2067)
- Evolutionary Biology (18308)
- Genetics (12245)
- Genomics (16803)
- Immunology (11869)
- Microbiology (28085)
- Molecular Biology (11592)
- Neuroscience (60969)
- Paleontology (451)
- Pathology (1871)
- Pharmacology and Toxicology (3238)
- Physiology (4959)
- Plant Biology (10427)
- Synthetic Biology (2885)
- Systems Biology (7340)
- Zoology (1651)